These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 36602040)

  • 1. Evaluation of a Digital Health Tool for Titration of Basal Insulin in People With Type 2 Diabetes: Rationale and Design of a Randomized Controlled Trial.
    Hermanns N; Ehrmann D; Finke-Gröne K; Roos T; Freckmann G; Kulzer B
    J Diabetes Sci Technol; 2024 Jul; 18(4):946-955. PubMed ID: 36602040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness and Safety of Physician-Led Versus Patient-Led Titration of Insulin Glargine in Indian Patients with Type 2 Diabetes Mellitus: A Subanalysis of the Asian Treat to Target Lantus Study (ATLAS).
    Misra A; Patel M; Agarwal P; Lodha S; Tandon N; Magdum M; Yajnik C; Ghosh R; Walekar A
    Diabetes Technol Ther; 2019 Nov; 21(11):656-664. PubMed ID: 31335198
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparable efficacy with similarly low risk of hypoglycaemia in patient- vs physician-managed basal insulin initiation and titration in insulin-naïve type 2 diabetic subjects: The Italian Titration Approach Study.
    Bonadonna RC; Giaccari A; Buzzetti R; Perseghin G; Cucinotta D; Avogaro A; Aimaretti G; Larosa M; Fanelli CG; Bolli GB
    Diabetes Metab Res Rev; 2020 Sep; 36(6):e3304. PubMed ID: 32118347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Web-based guided insulin self-titration in patients with type 2 diabetes: the Di@log study. Design of a cluster randomised controlled trial [TC1316].
    Roek MG; Welschen LM; Kostense PJ; Dekker JM; Snoek FJ; Nijpels G
    BMC Fam Pract; 2009 Jun; 10():40. PubMed ID: 19508712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Italian Titration Approach Study (ITAS) with insulin glargine 300 U/mL in insulin-naïve type 2 diabetes: Design and population.
    Bonadonna RC; Giaccari A; Buzzetti R; Aimaretti G; Cucinotta D; Avogaro A; Perseghin G; Larosa M; Bolli GB; Fanelli CG
    Nutr Metab Cardiovasc Dis; 2019 May; 29(5):496-503. PubMed ID: 30952575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and Safety of Basal Insulin-Based Treatment Versus Twice-Daily Premixed Insulin After Short-Term Intensive Insulin Therapy in Patients with Type 2 Diabetes Mellitus in China: Study Protocol for a Randomized Controlled Trial (BEYOND V).
    Liu J; Jiang X; Xu B; Wang G; Cui N; Zhang X; Liu J; Mu Y; Guo L
    Adv Ther; 2020 Apr; 37(4):1675-1687. PubMed ID: 32130661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Smartphone-Based Application to Assist Insulin Titration in Patients Undergoing Basal Insulin-Supported Oral Antidiabetic Treatment.
    Tews D; Gouveri E; Simon J; Marck C
    J Diabetes Sci Technol; 2023 Jul; 17(4):988-997. PubMed ID: 35491554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does a patient-managed insulin intensification strategy with insulin glargine and insulin glulisine provide similar glycemic control as a physician-managed strategy? Results of the START (Self-Titration With Apidra to Reach Target) Study: a randomized noninferiority trial.
    Harris SB; Yale JF; Berard L; Stewart J; Abbaszadeh B; Webster-Bogaert S; Gerstein HC
    Diabetes Care; 2014; 37(3):604-10. PubMed ID: 24170757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of smartphone application versus written titration charts for basal insulin titration in adults with type 2 diabetes and suboptimal glycaemic control (My Dose Coach): multicentre, open-label, parallel, randomised controlled trial.
    Hermanns N; Ehrmann D; Finke-Groene K; Krichbaum M; Roos T; Haak T; Freckmann G; Kulzer B
    Lancet Reg Health Eur; 2023 Oct; 33():100702. PubMed ID: 37954005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real-World Outcomes of Individualized Targeted Therapy with Insulin Glargine 300 Units/mL in Insulin-Naïve Korean People with Type 2 Diabetes: TOBE Study.
    Hong EG; Min KW; Lim JS; Ahn KJ; Ahn CW; Yu JM; Kim HS; Kim HJ; Kim W; Kim DH; Jang HC
    Adv Ther; 2024 May; 41(5):1967-1982. PubMed ID: 38512540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of diabetes self-management education via a smartphone application in insulin treated type 2 diabetes patients - design of a randomised controlled trial ('TRIGGER study').
    Boels AM; Rutten G; Zuithoff N; de Wit A; Vos R
    BMC Endocr Disord; 2018 Oct; 18(1):74. PubMed ID: 30348142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design of the DAVOS Study: Diabetes Smartphone App, a Fully Automatic Transmission of Data From the Blood Glucose Meter and Insulin Pens Using Wireless Technology to Enhance Diabetes Self-Management-A Study Protocol for a Randomized Controlled Trial.
    Grosser F; Herrmann S; Bretschneider M; Timpel P; Schildt J; Bentrup M; Schwarz PEH
    J Diabetes Sci Technol; 2023 May; 17(3):742-750. PubMed ID: 35393874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Insulin Glargine Up-titration vs Insulin Degludec/Liraglutide on Glycated Hemoglobin Levels in Patients With Uncontrolled Type 2 Diabetes: The DUAL V Randomized Clinical Trial.
    Lingvay I; Pérez Manghi F; García-Hernández P; Norwood P; Lehmann L; Tarp-Johansen MJ; Buse JB;
    JAMA; 2016 Mar; 315(9):898-907. PubMed ID: 26934259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Take Control: A randomized trial evaluating the efficacy and safety of self- versus physician-managed titration of insulin glargine 300 U/mL in patients with uncontrolled type 2 diabetes.
    Russell-Jones D; Dauchy A; Delgado E; Dimitriadis G; Frandsen HA; Popescu L; Schultes B; Strojek K; Bonnemaire M; Roborel de Climens A; Davies M
    Diabetes Obes Metab; 2019 Jul; 21(7):1615-1624. PubMed ID: 30851006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized Trial of Long-Acting Insulin Glargine Titration Web Tool (LTHome) Versus Enhanced Usual Therapy of Glargine Titration (INNOVATE Trial).
    Bajaj HS; Venn K; Ye C; Aronson R
    Diabetes Technol Ther; 2016 Oct; 18(10):610-615. PubMed ID: 27652718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term intensive insulin therapy could be the preferred option for new onset Type 2 diabetes mellitus patients with HbA1c > 9.
    Weng J
    J Diabetes; 2017 Oct; 9(10):890-893. PubMed ID: 28661564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Titration of Insulin Glargine in Patients with Type 2 Diabetes Mellitus in Asia: Physician- Versus Patient-Led? Rationale of the Asian Treat to Target Lantus Study (ATLAS).
    ATLAS Study Group
    Diabetes Technol Ther; 2011 Jan; 13(1):67-72. PubMed ID: 21175274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient-directed titration for achieving glycaemic goals using a once-daily basal insulin analogue: an assessment of two different fasting plasma glucose targets - the TITRATE study.
    Blonde L; Merilainen M; Karwe V; Raskin P;
    Diabetes Obes Metab; 2009 Jun; 11(6):623-31. PubMed ID: 19515182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights into optimal basal insulin titration in type 2 diabetes: Results of a quantitative survey.
    Berard L; Bonnemaire M; Mical M; Edelman S
    Diabetes Obes Metab; 2018 Feb; 20(2):301-308. PubMed ID: 28719066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of Smartphone App-Based Interactive Management on Glycemic Control in Chinese Patients With Poorly Controlled Diabetes: Randomized Controlled Trial.
    Zhang L; He X; Shen Y; Yu H; Pan J; Zhu W; Zhou J; Bao Y
    J Med Internet Res; 2019 Dec; 21(12):e15401. PubMed ID: 31815677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.